Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
FDA-approved for three indications with multiple active-comparator trials, cardiovascular outcomes data, and extensive post-marketing surveillance
Head-to-head comparison data demonstrates that tirzepatide outperforms semaglutide across most weight loss metrics
Anyone under the age of 18 isnt encouraged to take semaglutide
No Proven Clinical Link Large clinical studies, including the SURPASS programme, have not identified blood clots as a recognised adverse reaction linked with tirzepatide treatment
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
